Turn Therapeutics Cash Flow Statement (2024-2026) | TTRX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Sep2024	Dec2024	Mar2025	Sep2025	Dec2025	Mar2026	Jun2026
Operating Activities
Net Income (Quarter)	-1.03M	-0.47M	-0.57M	-7.58M	-2.93M	-3.15M	-12.23M
Share-based Compensation (Quarter)		0.04M	0.08M	0.31M	0.26M	1.20M	3.35M
Asset Writedowns and Impairment (Quarter)						0.48M	0.64M
Cash from Operations (Quarter)		-0.43M	-0.30M		-1.21M	-1.60M	-0.97M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)			0.01M			0.01M	0.01M
Change in Working Capital
Change in Accured Expenses (Quarter)		0.05M	-0.02M		0.66M	-0.61M	0.29M
Investing Activities
Cash from Investing Activities (Quarter)		-0.01M			-0.03M	-0.01M	-0.01M
Financing Activities
Change in Capital Stock
Shares Issued (Quarter)		1.58M		3.00M	1.94M	1.63M	2.71M
Net Equity Issued and Repurchased (Quarter)		75.00M	0.30M		3.18M
Misc.
Cash from Financing Activities (Quarter)		0.52M	1.00M		3.18M	7.79M	1.00
Change in Cash (Quarter)		0.08M	0.70M		1.97M	6.14M	-0.93M
Free Cash Flow (Quarter)		-0.43M	-0.30M		-1.21M	-1.60M	-0.97M
Net Cash Flow (Quarter)		0.08M	0.70M		1.94M	6.17M	-0.97M